Literature DB >> 24685237

Identifying association model for single-nucleotide polymorphisms of ORAI1 gene for breast cancer.

Wei-Chiao Chang1,2,3,4, Yong-Yuan Fang5, Hsueh-Wei Chang3,6,7, Li-Yeh Chuang8, Yu-Da Lin9, Ming-Feng Hou3,4,10, Cheng-Hong Yang9.   

Abstract

BACKGROUND: ORAI1 channels play an important role for breast cancer progression and metastasis. Previous studies indicated the strong correlation between breast cancer and individual single nucleotide polymorphisms (SNPs) of ORAI1 gene. However, the possible SNP-SNP interaction of ORAI1 gene was not investigated.
RESULTS: To develop the complex analyses of SNP-SNP interaction, we propose a genetic algorithm (GA) to detect the model of breast cancer association between five SNPs (rs12320939, rs12313273, rs7135617, rs6486795 and rs712853) of ORAI1 gene. For individual SNPs, the differences between case and control groups in five SNPs of ORAI1 gene were not significant. In contrast, GA-generated SNP models show that 2-SNP (rs12320939-GT/rs6486795-CT), 3-SNP (rs12320939-GT/rs12313273-TT/rs6486795-TC), 5-SNP (rs12320939-GG/rs12313273-TC/rs7135617-TT/rs6486795-TT/rs712853-TT) have higher risks for breast cancer in terms of odds ratio analysis (1.357, 1.689, and 13.148, respectively).
CONCLUSION: Taken together, the cumulative effects of SNPs of ORAI1 gene in breast cancer association study were well demonstrated in terms of GA-generated SNP models.

Entities:  

Year:  2014        PMID: 24685237      PMCID: PMC3994227          DOI: 10.1186/1475-2867-14-29

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


Background

Single nucleotide polymorphisms (SNPs) are one of the most common variants in human genome [1]. Currently, SNPs have been applied to the association studies for complex diseases [2-4]. Genome-wide association studies (GWAS) can identify the several SNPs predisposing to many diseases [5-8]. Although GWAS covers human genome-wide SNPs, many SNPs of non-significance are commonly ignored. Recently, the possible jointed effects of gene-gene interactions are gradually uncovered in predicting many disease risks [9-12]. However, when simultaneously evaluate the complex interactions amongst huge SNPs, these interactions are complex and it may need the help of new strategy [13] or computation [14]. Similarly, the non-GWAS association studies have the similar condition to ignore the possible gene-gene interactions. For example, several individual SNPs of the ORAI calcium release-activated calcium modulator 1 (ORAI1) gene have reported to be involved in breast cancer susceptibility [15]. However, the possible SNP-SNP interactions of ORAI1 gene associated with breast cancer were not addressed. Different computational analyses have been introduced to examine SNP-SNP interaction in many association studies [14,16-23]. Genetic algorithm (GA) is potential for feature selection for genome-wide scale datasets [24] and may apply to compute the difference between case and control groups to identify good models from the huge SNP combinations as well as tagSNP selection [25]. To address the possible SNP-SNP interaction in breast cancer susceptibility, five tagSNPs (rs12313273, rs6486795, rs7135617, rs12320939, and rs712853) of ORAI1 gene were selected in this study. Therefore, we introduced the GA to optimizing the analyses of SNP-SNP interactions of ORAI1 gene associated with breast cancer. GA is used to identify the best SNP models (SNP combinations with genotypes) with maximum frequency difference between breast cancer and control groups. Therefore, the best GA-generated SNP models of ORAI1 gene may be useful for predicting the breast cancer risk.

Methods

Data set collection

The case and control subjects are 345 female breast cancer patients and 290 female normal controls where the recruitment was approved by Cancer Center of Kaohsiung Medical University Hospital. The genotype dataset of breast cancer patients of five tagSNPs (rs12313273, rs6486795, rs7135617, rs12320939, and rs712853) of ORAI1 gene with minimum allele frequency (MAF) >10% obtained from our previous study [15]. For normal controls, samples of were collected in current study and SNP genotyping was performed as described [15].

Genetic algorithm

The GA [26] is a well-known evolutionary algorithm, and it has been applied for solving the complex problems in several fields. GA simulates the natural evolution to generate solutions of complex problems, including selection, crossover, mutation, and inheritance. The process of GA has six steps: (1) initializing population, (2) evaluate chromosome values, (3) select two parents using selection operation, (4) crossover operation, (5) mutation operation, and (6) replacement operation. A population in first step is initialized according encoding schemes of problem. Second step aims to evaluate value of chromosomes in population using fitness function. Third step use the evaluated value of chromosomes to select the two good parents for generating two offspring (step 4). Then firth step is probabilistic to mutate two offspring. Final step is used to improve the value of population. Thus repeat of steps 2 to 6 in several generations can effectively search the good values of chromosomes in population, and a best chromosome in population is regarded to best solution. Algorithm 1 shows the GA pseudo-code, and the below section is detailed to explain the processes of six steps. Algorithm 1: Genetic algorithm pseudo-code.

Encoding schemes

A population consists of the several possible solution of problem. The possible solution in GA is named a chromosome that is a set C = {c1, …, c }. In this study, a chromosome indicates a possible model of associations between SNPs. All combinations of SNPs and genotypes can be represented a set A = S × G = {(s, g)| s∈S and g∈G} where S is a set of SNPs and G is a set of genotypes. For example, we assume an S contains two SNPs and a G contains three genotypes, i.e., S = {s1, s2} and G = {g1, g2, g3}. All possible subsets can be represented A = S × G = {(s1, g1), (s1, g2), (s1, g3), (s2, g1), (s2, g2), (s2, g3)}. Each subset in A represents the selected SNP and their genotype. A chromosome is defined C = {c1, …, c | c , c ∈A, c  ≠ c , 1 ≤ i ≠ j ≤ d} where d is the association model size. A possible chromosome in above example can be assigned as C = {(s1, g1), (s2, g2)}; it means a model that includes the genotype “AA” of first SNP and the genotype “Aa” of second SNP.

Fitness function

A value of chromosome C can be evaluated by computing the fitness function; it facilitates GA for eliminating the worst chromosomes of population in each generation. In this study, a total number difference between case data and control data at a model is used to design a fitness function. Equation 1 is used to check a model whether a SNP is repeatedly selected or not. If a SNP is repeatedly selected in a C, the value of C is evaluated to zero. If it is not, Equation 2 is used to calculate the total number difference between cases and controls at a model. In Equation 2, the max_P and max_N are a total number of case data and a total number of control data, respectively. The P and N are respectively represented the set of case data and a set of control data; P is the ith patient sample in case data and N is the ith normal sample in control data. Equation 3 is used to evaluate whether all factors in a model are included in a set of sample. If a sample includes the model, the Equation 3 returns one value into Equation 2; whereas, it returns zero value.

Selection operation

Selection operation aims to select the good chromosomes for generating the great offspring; the selected chromosomes name parents. Selection operation in this study uses a rank-based tournament scheme for selecting the two parents. The operation uses fitness function to evaluate all chromosomes of a population P = {C1, …, C |i is population size}, and all values in P are recorded into a set R = {r1, …, r | i is population size}. These values represent chromosome ranks. Then R is sorted from the big value to small value, i.e., r1 ≥ r2 ≥ r . Thus the r1 and r2 with corresponding Cs in P are two selected parents.

Crossover operation

Crossover operation is used to generate the offspring from the parents, and the operation use a uniform crossover scheme. Uniform crossover firstly generate a binary mask set B = {b1, …, b | b∈[0,1], i = |C|}; a binary value at b is randomly generated. The one value of b indicates that jth elements of two parents are must be exchanged; the zero value represents the no exchange. Two offspring are generated by exchanging the elements of two parents according the binary mask set, and the offspring are represented C’. For example, let a generated binary mask B = {1, 0, 1, 0} and two parents C1 = {(s1, g1), (s2, g2), (s5, g1), (s3, g3)} and C2 = {(s1, g3), (s2, g1), (s4, g2), (s3, g2)}. The generated two offspring are C’1 = {(s1, g3), (s2, g2), (s4, g2), (s3, g3)} and C’2 = {(s1, g1), (s2, g1), (s5, g1), (s3, g2)}, respectively.

Mutation operation

Mutation operation can facilitate the diversity of chromosomes in population, and avoid population for trapping the local optimal. The operation uses a one-point mutation operation. A mutation point set M = {m1, …, m | m∈[0,1], i = |C|} is used to indicate the mutation points in the offspring C’. Each binary value in M is randomly generated according to the mutation probability. The one value of m represents that jth element of C do the mutation; the zero value represents the no mutation. The mutation randomly generates a possible c element, where c∈A, to replace the original element at a mutation point. For example, let a generated mutation point M = {0, 0, 1, 0} and offspring C’1 = {(s1, g3), (s2, g2), (s4, g2), (s3, g3)}. Suppose the number of SNPs is five, a possible set is E = {(s4, g1), (s4, g2), (s4, g3), (s5, g1), (s5, g2), (s5, g3)}. After mutation the offspring could be C’1 = {(s1, g3), (s2, g2), (s5, g3), (s3, g3)}.

Replacement operation

Replacement operation aims to gradually improve value of population. The generated two offspring C’1 and C’2 are evaluated by fitness function, and are used to compare the value to all chromosomes. When an offspring is higher value than a chromosome of population, it replaces the chromosome; otherwise, the offspring is deleted.

Parameter settings

In the GA parameters, both of the exchange probabilities in the tournament selection and uniform crossover are 1.0. The exchange probability of a one-point mutation is 0.1. The population size is 50, and the number of generations is 100.

Statistical analysis

All statistical value is computed using SPSS version 19.0 (SPSS Inc., Chicago, IL). Odds ratio (OR) with 95% confidence interval (CI) is used for measuring a single SNP and the model of association between SNPs; a P value of < 0.05 is considered statistically significant difference between the cases and controls.

Results

Data collection

The complete genotype data set is available at http://bioinfo.kmu.edu.tw/BRCA-ORAI1-5SNPs.xlsx. Based on these data, the GA-generated SNP models to address the possible SNP-SNP interaction in ORAI1 gene were evaluated in terms of breast cancer association later.

Comparison of patients and normal in terms of effect of single SNP

Table 1 shows the occurrence of breast cancer for five SNPs in ORAI1 gene. The genotype with major allele (G in rs12320939; T in rs12313273; G in rs7135617; T in rs6486795; and T in rs712853) is regarded as the reference for analyzing breast cancer risks in terms of single SNPs. Minor allele is selected according the dbSNP database of NCBI (National Center for Biotechnology Information). No significant differences between the breast cancer patients and controls in all genotypes for each single SNP were found.
Table 1

The performance of five individual SNPs for breast cancer and control groups

SNP IDGenotypeCase (%)Control (%) p -value
1. rs12320939
GG
97
(28.12)
79
(27.24)
 
 
GT
181
(52.46)
140
(48.28)
0.785
 
TT
67
(19.42)
71
(24.48)
0.248
2. rs12313273
TT
183
(53.04)
161
(55.52)
 
 
TC
142
(41.16)
100
(34.48)
0.189
 
CC
20
(5.80)
29
(10.00)
0.107
3. rs7135617
GG
103
(29.86)
94
(32.41)
 
 
GT
187
(54.20)
145
(50.00)
0.367
 
TT
55
(15.94)
51
(17.59)
0.947
4. rs6486795
TT
137
(39.71)
121
(41.72)
 
 
TC
173
(50.14)
126
(43.45)
0.260
 
CC
35
(10.14)
43
(14.83)
0.204
5. rs712853
TT
154
(44.64)
128
(44.14)
 
 
TC
158
(45.80)
134
(46.21)
0.904
 CC33(9.57)28(9.66)0.942
The performance of five individual SNPs for breast cancer and control groups

Identification of the best model of SNPs association with maximum frequency difference between breast cancer and control groups

During GA processing, the best ten models of two SNP combinations with genotypes (2-SNP models) were demonstrated in Table 2. In these 2-SNP models, the SNPs (1, 4) with genotype 2-2, i.e., [rs12320939-GT]-[rs6486795-TC], possessed the maximum frequency difference (7.20%) between the breast cancer and control groups, namely the best 2-SNP model. Similarly, the best GA-generated SNP models involving three to five SNP were shown in left side of Table 3.
Table 2

The best 10 models in 2-SNP order association

Combined SNP number (specific SNPs)SNP GenotypesCase no.Control no.Difference (%)*
SNP(1,4)
2-2
145
101
7.20
SNP(2,4)
2-3
22
1
6.03
SNP(3,4)
2-2
121
85
5.76
SNP(2,5)
2-3
83
54
5.44
SNP(2,4)
3-2
65
40
5.05
SNP(1,5)
2-3
81
55
4.51
SNP(4,5)
2-3
81
55
4.51
SNP(3,5)
2-3
78
53
4.33
SNP(2,3)
3-3
38
23
3.08
SNP(4,5)
2-2
77
56
3.01
SNP(1,3)2-21471162.61

*Difference (%) = Frequency of cases (breast cancer group) - Frequency of controls.

Table 3

The odds ratio of the best SNP models associated with breast cancer

Combined SNP no. (specific SNPs)SNP GenotypesCase no./control no.Cancer (%)Difference (%)*Odds ratio (95%CI) P value
2-SNP (1-4)
2-2
145/101
58.94
7.20
1.357
0.064
 
Others
200/189
51.41
 
(0.983-1.873)
 
3-SNP (1-2-4)
2-1-2
58/31
65.17
6.12
1.689
0.028
 
Others
287/259
52.56
 
(1.058-2.694)
 
4-SNP (1-3-4-5)
2-2-2-1
78/53
59.54
4.33
1.306
0.180
 
others
267/237
52.98
 
(0.884-1.930)
 
5-SNP (1-2-3-4-5)
1-2-3-1-1
14/0
100.00
4.06
13.148
0.013
 Others331/29053.30 (1.726-100.142) 

Bold letters: The SNP models associated with breast cancer are significant (P value < 0.05).

*Difference (%) = Frequency of cases (breast cancer group) - Frequency of controls.

The best 10 models in 2-SNP order association *Difference (%) = Frequency of cases (breast cancer group) - Frequency of controls. The odds ratio of the best SNP models associated with breast cancer Bold letters: The SNP models associated with breast cancer are significant (P value < 0.05). *Difference (%) = Frequency of cases (breast cancer group) - Frequency of controls.

Odds ratio analysis to identify the best models of SNP associations associated with high breast cancer

Table 3 shows five best models of association involving two to five SNPs. Odds ratio analysis shows the performance (OR, 95% CI, and P value) of five types of the best models (2- to 5-SNP models) addressing the breast cancer association. The 2-SNP model, i.e., SNPs (1, 4) in genotype 2-2, indicates the borderline significance with breast cancer (OR: 1.357, P = 0.064). The 3-SNP model, i.e., SNPs (1, 2, 4) in genotype 2-1-2, indicates three SNPs (rs12320939, rs12313273, and rs6486795) have a significant association when their genotypes are GT, TT, and TC, respectively (OR: 1.689, P = 0.028). The 5-SNP model, SNPs (1, 2, 3, 4, 5) in genotype 1-2-3-1-1, indicates all SNPs (rs12320939, rs12313273, rs7135617, rs6486795, and rs712853) have a strongly association when their genotypes are GG, TC, TT, TT, and TT, respectively (OR: 13.148, P = 0.013).

Discussion

GA is a robust non-parametric method that detects nonlinear interactions amongst multiple discrete genetic factors. The advantage of GA is that the method can directly search the good models from the huge number of possible combinations without the training data set. In this study, the fitness function is designed based on the unbalanced data set to compute the difference between case data set and control data set. The function can effectively measure high-risk to search the good model in real data set. In current study, the OR values of 2- to 3-SNP models are larger than 1 but small, suggesting that the cumulative effect of these four SNPs (rs12320939, rs7135617, rs6486795, and rs712853) are weak. When five SNPs included, the OR value is 13.148, indicating that the cumulative effect of 5-SNP model becomes strong. This unstable cumulative effect of SNP combinations in SNP models may be partly explained by the experiment design that these five SNPs were only derived from a single gene ORAI1. Because breast cancer is a kind of multigene disease [27-30], therefore, SNPs derived from more genes included in association studies may reveal the cumulative effect effectively [9,11,12,31-33]. Accordingly, the differential performance of the cumulative effects of SNPs from single gene and multigene is worth of further investigation in future. The computational complexity of GA is calculated by a fitness function of computation. Suppose n iterations is implemented in a test, the computational complexity of GA is O(n) which represents the big-O in complexity analysis. GA in search of good association model has the below advantages: (1) GA effectively identify the high-risk models in high-order interaction, (2) the best model with statistical significant can be fast identified, and (3) it only has two parameters to need setting and is easily to fulfil for searching the good model. Further, GA is able to analyze high order SNP interactions amongst the huge number of SNPs from GWAS and pharmacogenomics studies in our experiences.

Conclusions

Although the polymorphisms of ORAI1 gene have been reported to associate with inflammatory diseases [34-36], effects of SNP-SNP interaction to diseases are still unclear. In this study, the GA successfully identified appropriate models of SNP-SNP interactions in breast cancer association study in terms of five SNPs in ORAI1 gene. The resulting SNP models can predict the breast cancer susceptibility more effective than the individual SNPs. This methodology can also apply to any kinds of SNP association studies, such as GWAS, pharmacogenomics and others. Therefore, the possible cumulative effect of SNP combination will be uncovered by this methodology.

Competing interests

The authors have no competing interests to declare.

Authors’ contributions

W-CC and M-FH carried out the molecular genetic studies. W-CC and Y-YF drafted the manuscript. C-HY instructed Y-DL to perform SNP interaction analysis by algorithm. Y-YF, H-WC, and L-YC performed statistics analyses. H-WC, C-HY, and M-FH were involved in discussion and editing the manuscript. All authors read and approved the final manuscript.
  33 in total

1.  Single nucleotide polymorphism barcoding to evaluate oral cancer risk using odds ratio-based genetic algorithms.

Authors:  Cheng-Hong Yang; Li-Yeh Chuang; Yu-Huei Cheng; Yu-Da Lin; Chun-Lin Wang; Cheng-Hao Wen; Hsueh-Wei Chang
Journal:  Kaohsiung J Med Sci       Date:  2012-05-14       Impact factor: 2.744

2.  Disease genetics: a Mendelian code for complex disease.

Authors:  Louisa Flintoft
Journal:  Nat Rev Genet       Date:  2013-11       Impact factor: 53.242

3.  Multigene assays for late recurrence of breast cancer.

Authors:  Michail Ignatiadis
Journal:  Lancet Oncol       Date:  2013-09-12       Impact factor: 41.316

4.  Computational analysis of simulated SNP interactions between 26 growth factor-related genes in a breast cancer association study.

Authors:  Cheng-Hong Yang; Li-Yeh Chuang; Yu-Jung Chen; Hung-Fu Tseng; Hsueh-Wei Chang
Journal:  OMICS       Date:  2011-05-20

5.  Preventive SNP-SNP interactions in the mitochondrial displacement loop (D-loop) from chronic dialysis patients.

Authors:  Jin-Bor Chen; Li-Yeh Chuang; Yu-Da Lin; Chia-Wei Liou; Tsu-Kung Lin; Wen-Chin Lee; Ben-Chung Cheng; Hsueh-Wei Chang; Cheng-Hong Yang
Journal:  Mitochondrion       Date:  2013-02-15       Impact factor: 4.160

6.  A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ.

Authors:  Shivani Duggal; Thomas B Julian
Journal:  J Natl Cancer Inst       Date:  2013-05-02       Impact factor: 13.506

7.  A second generation human haplotype map of over 3.1 million SNPs.

Authors:  Kelly A Frazer; Dennis G Ballinger; David R Cox; David A Hinds; Laura L Stuve; Richard A Gibbs; John W Belmont; Andrew Boudreau; Paul Hardenbol; Suzanne M Leal; Shiran Pasternak; David A Wheeler; Thomas D Willis; Fuli Yu; Huanming Yang; Changqing Zeng; Yang Gao; Haoran Hu; Weitao Hu; Chaohua Li; Wei Lin; Siqi Liu; Hao Pan; Xiaoli Tang; Jian Wang; Wei Wang; Jun Yu; Bo Zhang; Qingrun Zhang; Hongbin Zhao; Hui Zhao; Jun Zhou; Stacey B Gabriel; Rachel Barry; Brendan Blumenstiel; Amy Camargo; Matthew Defelice; Maura Faggart; Mary Goyette; Supriya Gupta; Jamie Moore; Huy Nguyen; Robert C Onofrio; Melissa Parkin; Jessica Roy; Erich Stahl; Ellen Winchester; Liuda Ziaugra; David Altshuler; Yan Shen; Zhijian Yao; Wei Huang; Xun Chu; Yungang He; Li Jin; Yangfan Liu; Yayun Shen; Weiwei Sun; Haifeng Wang; Yi Wang; Ying Wang; Xiaoyan Xiong; Liang Xu; Mary M Y Waye; Stephen K W Tsui; Hong Xue; J Tze-Fei Wong; Luana M Galver; Jian-Bing Fan; Kevin Gunderson; Sarah S Murray; Arnold R Oliphant; Mark S Chee; Alexandre Montpetit; Fanny Chagnon; Vincent Ferretti; Martin Leboeuf; Jean-François Olivier; Michael S Phillips; Stéphanie Roumy; Clémentine Sallée; Andrei Verner; Thomas J Hudson; Pui-Yan Kwok; Dongmei Cai; Daniel C Koboldt; Raymond D Miller; Ludmila Pawlikowska; Patricia Taillon-Miller; Ming Xiao; Lap-Chee Tsui; William Mak; You Qiang Song; Paul K H Tam; Yusuke Nakamura; Takahisa Kawaguchi; Takuya Kitamoto; Takashi Morizono; Atsushi Nagashima; Yozo Ohnishi; Akihiro Sekine; Toshihiro Tanaka; Tatsuhiko Tsunoda; Panos Deloukas; Christine P Bird; Marcos Delgado; Emmanouil T Dermitzakis; Rhian Gwilliam; Sarah Hunt; Jonathan Morrison; Don Powell; Barbara E Stranger; Pamela Whittaker; David R Bentley; Mark J Daly; Paul I W de Bakker; Jeff Barrett; Yves R Chretien; Julian Maller; Steve McCarroll; Nick Patterson; Itsik Pe'er; Alkes Price; Shaun Purcell; Daniel J Richter; Pardis Sabeti; Richa Saxena; Stephen F Schaffner; Pak C Sham; Patrick Varilly; David Altshuler; Lincoln D Stein; Lalitha Krishnan; Albert Vernon Smith; Marcela K Tello-Ruiz; Gudmundur A Thorisson; Aravinda Chakravarti; Peter E Chen; David J Cutler; Carl S Kashuk; Shin Lin; Gonçalo R Abecasis; Weihua Guan; Yun Li; Heather M Munro; Zhaohui Steve Qin; Daryl J Thomas; Gilean McVean; Adam Auton; Leonardo Bottolo; Niall Cardin; Susana Eyheramendy; Colin Freeman; Jonathan Marchini; Simon Myers; Chris Spencer; Matthew Stephens; Peter Donnelly; Lon R Cardon; Geraldine Clarke; David M Evans; Andrew P Morris; Bruce S Weir; Tatsuhiko Tsunoda; James C Mullikin; Stephen T Sherry; Michael Feolo; Andrew Skol; Houcan Zhang; Changqing Zeng; Hui Zhao; Ichiro Matsuda; Yoshimitsu Fukushima; Darryl R Macer; Eiko Suda; Charles N Rotimi; Clement A Adebamowo; Ike Ajayi; Toyin Aniagwu; Patricia A Marshall; Chibuzor Nkwodimmah; Charmaine D M Royal; Mark F Leppert; Missy Dixon; Andy Peiffer; Renzong Qiu; Alastair Kent; Kazuto Kato; Norio Niikawa; Isaac F Adewole; Bartha M Knoppers; Morris W Foster; Ellen Wright Clayton; Jessica Watkin; Richard A Gibbs; John W Belmont; Donna Muzny; Lynne Nazareth; Erica Sodergren; George M Weinstock; David A Wheeler; Imtaz Yakub; Stacey B Gabriel; Robert C Onofrio; Daniel J Richter; Liuda Ziaugra; Bruce W Birren; Mark J Daly; David Altshuler; Richard K Wilson; Lucinda L Fulton; Jane Rogers; John Burton; Nigel P Carter; Christopher M Clee; Mark Griffiths; Matthew C Jones; Kirsten McLay; Robert W Plumb; Mark T Ross; Sarah K Sims; David L Willey; Zhu Chen; Hua Han; Le Kang; Martin Godbout; John C Wallenburg; Paul L'Archevêque; Guy Bellemare; Koji Saeki; Hongguang Wang; Daochang An; Hongbo Fu; Qing Li; Zhen Wang; Renwu Wang; Arthur L Holden; Lisa D Brooks; Jean E McEwen; Mark S Guyer; Vivian Ota Wang; Jane L Peterson; Michael Shi; Jack Spiegel; Lawrence M Sung; Lynn F Zacharia; Francis S Collins; Karen Kennedy; Ruth Jamieson; John Stewart
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

8.  The cumulative effects of polymorphisms in the DNA mismatch repair genes and tobacco smoking in oesophageal cancer risk.

Authors:  Matjaz Vogelsang; Yabing Wang; Nika Veber; Lamech M Mwapagha; M Iqbal Parker
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  Prediction of disease and phenotype associations from genome-wide association studies.

Authors:  Stephanie N Lewis; Elaine Nsoesie; Charles Weeks; Dan Qiao; Liqing Zhang
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

10.  The association between single-nucleotide polymorphisms of ORAI1 gene and breast cancer in a Taiwanese population.

Authors:  Wei-Chiao Chang; Peng Yeong Woon; Yu-Wen Hsu; Shengyu Yang; Yi-Ching Chiu; Ming Feng Hou
Journal:  ScientificWorldJournal       Date:  2012-06-18
View more
  11 in total

Review 1.  The role of Orai-STIM calcium channels in melanocytes and melanoma.

Authors:  Hedwig Stanisz; Adina Vultur; Meenhard Herlyn; Alexander Roesch; Ivan Bogeski
Journal:  J Physiol       Date:  2016-04-06       Impact factor: 5.182

2.  Identification of High-Order Single-Nucleotide Polymorphism Barcodes in Breast Cancer Using a Hybrid Taguchi-Genetic Algorithm: Case-Control Study.

Authors:  Cheng-Hong Yang; Li-Yeh Chuang; Cheng-San Yang; Huai-Shuo Yang
Journal:  JMIR Med Inform       Date:  2020-06-17

3.  The Combinational Polymorphisms of ORAI1 Gene Are Associated with Preventive Models of Breast Cancer in the Taiwanese.

Authors:  Fu Ou-Yang; Yu-Da Lin; Li-Yeh Chuang; Hsueh-Wei Chang; Cheng-Hong Yang; Ming-Feng Hou
Journal:  Biomed Res Int       Date:  2015-08-25       Impact factor: 3.411

4.  Data Acquisition and Processing in Biology and Medicine.

Authors:  Cheng-Hong Yang; Yu-Jie Huang; An Liu; Yi Rong; Tsair-Fwu Lee
Journal:  Biomed Res Int       Date:  2015-08-26       Impact factor: 3.411

5.  Predicting the combined effect of multiple genetic variants.

Authors:  Mingming Liu; Layne T Watson; Liqing Zhang
Journal:  Hum Genomics       Date:  2015-07-30       Impact factor: 4.639

6.  Development and Application of a Genetic Algorithm for Variable Optimization and Predictive Modeling of Five-Year Mortality Using Questionnaire Data.

Authors:  Lucas J Adams; Ghalib Bello; Gerard G Dumancas
Journal:  Bioinform Biol Insights       Date:  2015-11-08

7.  SNP 1772 C > T of HIF-1α gene associates with breast cancer risk in a Taiwanese population.

Authors:  Chih-Jen Huang; Shi-Long Lian; Ming-Feng Hou; Chee-Yin Chai; Yi-Hsing Yang; Sheng-Fung Lin; Hsueh-Wei Chang
Journal:  Cancer Cell Int       Date:  2014-09-26       Impact factor: 5.722

8.  TRPC6 Channels Are Required for Proliferation, Migration and Invasion of Breast Cancer Cell Lines by Modulation of Orai1 and Orai3 Surface Exposure.

Authors:  Isaac Jardin; Raquel Diez-Bello; Jose J Lopez; Pedro C Redondo; Ginés M Salido; Tarik Smani; Juan A Rosado
Journal:  Cancers (Basel)       Date:  2018-09-14       Impact factor: 6.639

9.  Relationship between Clinicopathologic Variables in Breast Cancer Overall Survival Using Biogeography-Based Optimization Algorithm.

Authors:  Li-Yeh Chuang; Guang-Yu Chen; Sin-Hua Moi; Fu Ou-Yang; Ming-Feng Hou; Cheng-Hong Yang
Journal:  Biomed Res Int       Date:  2019-04-01       Impact factor: 3.411

Review 10.  Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers.

Authors:  Zhengfeng Yang; Zhiying Yue; Xinrun Ma; Zhenyao Xu
Journal:  Front Oncol       Date:  2020-03-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.